Cancer stem cells in colorectal cancer from pathogenesis to therapy: Controversies and perspectives

doi:10.3748/wjg.v20.i4.923

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 4

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12331)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-12) series, Tables (1-3) series.

Item

Count

PDF

753

WORD

421

HTML

8662

Figures (1-12)

371

Tables (1-3)

144

Sum=10351

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1123

Download

857

Sum=1980

Jan 28, 2014 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (77)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Jan 28, 2014; 20(4): 923-942
Published online Jan 28, 2014. doi: 10.3748/wjg.v20.i4.923

Table 2 Prognostic value of CD133

Marker	Prognostic value	Ref.
CD133	Worse outcome and higher risk of metastasis	[32]
	Independent prognostic marker for overall survival	[33]
	Association with CSC resistance to 5FU-based chemotherapy in CRC	[34]
	Association with resistance to conventional radiotherapy in CRC	[35]
	Prediction of distant recurrences after chemoradiotherapy in colon cancer patients	[35]
	High tumorigenicity of CD133⁺ CRC cells compared to CD133^- cells due to their interaction with CAFs by paracrine signaling axis of CXCR4-SDF1	[36]
	Risk factor for poor overall survival in stage II and III in colon cancer patients	[37]
	Relationship with K-Ras and B-Raf mutations in CRC patients	[38]

CSC: Cancer stem cell; CRC: Colorectal cancer.

Citation: Fanali C, Lucchetti D, Farina M, Corbi M, Cufino V, Cittadini A, Sgambato A. Cancer stem cells in colorectal cancer from pathogenesis to therapy: Controversies and perspectives. World J Gastroenterol 2014; 20(4): 923-942
URL: https://www.wjgnet.com/1007-9327/full/v20/i4/923.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i4.923